IL100452A - Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist - Google Patents
Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonistInfo
- Publication number
- IL100452A IL100452A IL10045291A IL10045291A IL100452A IL 100452 A IL100452 A IL 100452A IL 10045291 A IL10045291 A IL 10045291A IL 10045291 A IL10045291 A IL 10045291A IL 100452 A IL100452 A IL 100452A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- receptor antagonist
- effervescent pharmaceutical
- effervescent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909027827A GB9027827D0 (en) | 1990-12-21 | 1990-12-21 | Pharmaceutical compositions |
SG169594A SG169594G (en) | 1990-12-21 | 1994-12-01 | Effervescent pharmaceutical compositions containing a 5HT-receptor agonist |
Publications (2)
Publication Number | Publication Date |
---|---|
IL100452A0 IL100452A0 (en) | 1992-09-06 |
IL100452A true IL100452A (en) | 1997-02-18 |
Family
ID=26298162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10045291A IL100452A (en) | 1990-12-21 | 1991-12-20 | Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0563094B1 (cs) |
JP (1) | JP3425949B2 (cs) |
KR (1) | KR100188172B1 (cs) |
AT (1) | ATE127688T1 (cs) |
AU (1) | AU654313B2 (cs) |
BE (1) | BE1004182A3 (cs) |
CA (1) | CA2099585C (cs) |
CH (1) | CH684161A5 (cs) |
CZ (1) | CZ281042B6 (cs) |
DE (1) | DE69113062T2 (cs) |
DK (1) | DK0563094T3 (cs) |
ES (1) | ES2078727T3 (cs) |
FR (1) | FR2670674B1 (cs) |
GB (2) | GB9027827D0 (cs) |
GR (1) | GR3017701T3 (cs) |
HK (1) | HK18795A (cs) |
IE (1) | IE914482A1 (cs) |
IL (1) | IL100452A (cs) |
IT (1) | IT1252599B (cs) |
MX (1) | MX9102733A (cs) |
NZ (1) | NZ241098A (cs) |
RU (1) | RU2110992C1 (cs) |
SG (1) | SG169594G (cs) |
WO (1) | WO1992011003A1 (cs) |
ZA (1) | ZA9110052B (cs) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2714064B1 (fr) * | 1993-12-16 | 1996-03-08 | Edmond Creppy | Aspartame pour son application en tant que substance thérapeutiquement active. |
GB0129117D0 (en) * | 2001-12-05 | 2002-01-23 | Glaxo Group Ltd | Pharmaceutical composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
IE59106B1 (en) * | 1985-05-31 | 1994-01-12 | Warner Lambert Co | A therapeutic effervescent composition and a method of preparing the same |
FR2593065B1 (fr) * | 1986-01-22 | 1988-09-09 | Smith Kline French Lab | Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation. |
GB8909793D0 (en) * | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
-
1990
- 1990-12-21 GB GB909027827A patent/GB9027827D0/en active Pending
-
1991
- 1991-12-17 KR KR1019930701894A patent/KR100188172B1/ko not_active IP Right Cessation
- 1991-12-17 DK DK92900531.2T patent/DK0563094T3/da active
- 1991-12-17 RU RU93044224A patent/RU2110992C1/ru not_active IP Right Cessation
- 1991-12-17 JP JP50165892A patent/JP3425949B2/ja not_active Expired - Fee Related
- 1991-12-17 CA CA002099585A patent/CA2099585C/en not_active Expired - Fee Related
- 1991-12-17 EP EP92900531A patent/EP0563094B1/en not_active Expired - Lifetime
- 1991-12-17 AT AT92900531T patent/ATE127688T1/de not_active IP Right Cessation
- 1991-12-17 WO PCT/EP1991/002425 patent/WO1992011003A1/en active IP Right Grant
- 1991-12-17 ES ES92900531T patent/ES2078727T3/es not_active Expired - Lifetime
- 1991-12-17 AU AU90665/91A patent/AU654313B2/en not_active Ceased
- 1991-12-17 DE DE69113062T patent/DE69113062T2/de not_active Expired - Fee Related
- 1991-12-17 CZ CS931225A patent/CZ281042B6/cs not_active IP Right Cessation
- 1991-12-19 GB GB9126957A patent/GB2250917B/en not_active Expired - Fee Related
- 1991-12-20 IT ITRM910963A patent/IT1252599B/it active IP Right Grant
- 1991-12-20 CH CH3791/91A patent/CH684161A5/fr not_active IP Right Cessation
- 1991-12-20 BE BE9101174A patent/BE1004182A3/fr not_active IP Right Cessation
- 1991-12-20 NZ NZ241098A patent/NZ241098A/en unknown
- 1991-12-20 IE IE448291A patent/IE914482A1/en not_active IP Right Cessation
- 1991-12-20 ZA ZA9110052A patent/ZA9110052B/xx unknown
- 1991-12-20 MX MX9102733A patent/MX9102733A/es not_active IP Right Cessation
- 1991-12-20 FR FR9115879A patent/FR2670674B1/fr not_active Expired - Fee Related
- 1991-12-20 IL IL10045291A patent/IL100452A/xx not_active IP Right Cessation
-
1994
- 1994-12-01 SG SG169594A patent/SG169594G/en unknown
-
1995
- 1995-02-09 HK HK18795A patent/HK18795A/xx not_active IP Right Cessation
- 1995-10-11 GR GR950402810T patent/GR3017701T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO921835D0 (no) | Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav | |
TW215434B (cs) | ||
SE8700498D0 (sv) | Novel pharmaceologically active compounds | |
HRP980163B1 (en) | Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates | |
ZA925128B (en) | Pyrrolidine derivatives,their preparation and medicaments containing them | |
DE69425655D1 (de) | Antagonisten des fibrinogenrezeptors | |
ZA832292B (en) | Salicylic acid derivatives,processes for their preparation,pharmaceutical for mulations based on these compounds and their use | |
IL100452A (en) | Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist | |
PH18186A (en) | Isoquinoline derivatives,a process for their preparation pharmaceutical formulations based on these compounds and the use thereof | |
TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
CS240991A3 (en) | Solid forms for oral administration, said forms containing iphosphamide as active component | |
HU9500175D0 (en) | Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives | |
ES2164168T3 (es) | Antagonistas de receptores de fibrinogeno que tienen residuos de beta-aminoacido sustituidos y composiciones farmaceuticas que comprenden los mismos. | |
EP0418990A3 (en) | 13-bromo and 13,14-dibromo ergoline, their preparation and their use | |
UA27784C2 (uk) | Шипуча фармацевтична композиція для орального введення | |
IL89126A0 (en) | Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them | |
IT1273528B (it) | Agonisti del recettore a3 della adenosina e composizioni farmaceutiche che li contengono | |
IT1252568B (it) | Derivati pirimidinici sostituiti da eteroarili ad attivita' a ii antagonista | |
ITPD920141A1 (it) | Formulazioni farmaceutiche per la somministraziane orale di calcitonina | |
IT1254565B (it) | Forma cristallina dell'endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato | |
CO4930293A1 (es) | Derivados de 5-triazolil-2,3(1h,4h)-quinoxalinadiona que son antagonistas selectivos de receptores de n-metil-d-aspartato |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NP | Permission for amending the patent specification granted (section 66, patents law 1967) | ||
CB | Opposition filed against grant of patent | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |